MedTrace Logo

Epidemiology of Impaired Coagulant Balance in Diabetes

NCT00005481 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-05-13

No results posted yet for this study

Summary

To determine the nature, extent and molecular mechanisms responsible for impaired fibrinolysis in White, Black, Hispanic and American Indian populations with respect to the presence or absence of diabetes. The overall objective is to determine whether impairments of fibrinolysis underlie subclinical and clinical vascular disease in diabetes in specific populations with and without accelerated microvascular disease.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Russell Tracy · University of Vermont

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-09-30
Completion
2002-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005481 on ClinicalTrials.gov